U.S. adults who haven't gotten any COVID-19 shots yet should consider a new option from Novavax—a more traditional kind of vaccine, influential government advisers said Tuesday.
Jul 19, 2022
0
2
The new BA.5 is one of the "worst" subvariants circulating the country, infecting even those who have immunity from previous infections and vaccines.
Jul 15, 2022
0
15
People with hematologic malignancies—or blood cancers including leukemia, lymphoma, and multiple myeloma—have an impaired immune system due to their disease and its treatment, putting them at risk of severe COVID-19 infection ...
Jul 11, 2022
0
3
COVID vaccination is highly protective against severe disease in people of all body weights, new British research finds.
Jul 5, 2022
0
6
A major clinical trial, led by experts at the University of Nottingham working in partnership with several universities and NHS hospitals, has found that interrupting the treatment of vulnerable people on long-term immune-suppressing ...
Jun 27, 2022
0
59
Moderna is seeking authorization from the U.S. Food and Drug Administration for a COVID-19 vaccine that adds protection specifically against the omicron variant of the coronavirus.
Jun 14, 2022
0
13
French drug maker Sanofi said Monday a COVID booster shot it is developing with Britain's GlaxoSmithKline has produced positive results against Omicron and other variants in clinical trials.
Jun 13, 2022
0
7
With COVID-19 cases rising again in the Bay Area, parents have a new consideration for protecting their children this week: The Food and Drug Administration granted emergency use authorization Tuesday for kids ages 5-11 to ...
May 19, 2022
0
1
With yet another COVID-19 booster available for vulnerable populations in the U.S., many people find themselves wondering what the end game will be.
Apr 18, 2022
0
133
The European Medicines Agency said it has authorized Moderna's coronavirus vaccine for children aged six to 11, in addition to recommending booster shots of Pfizer's vaccine for those aged 12 and over, in decisions aimed ...
Mar 3, 2022
0
15
